WallStreetZenWallStreetZen

NASDAQ: SHC
Sotera Health Co Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

SHC past earnings growth

How has SHC's earnings growth performed historically?
Company
N/A
Industry
-10.79%
Market
71.87%
SHC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
SHC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

SHC past revenue growth

How has SHC's revenue growth performed historically?
Company
4.54%
Industry
0.12%
Market
17.2%
SHC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SHC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SHC's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SHC earnings and revenue history

Current Revenue
$1.0B
Current Earnings
$51.4M
Current Profit Margin
4.9%

SHC Return on Equity

Current Company
12.8%
Current Industry
-24%
Current Market
188%
SHC's Return on Equity (12.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SHC announces earnings.

SHC Return on Assets

Current Company
1.6%
Current Industry
6.7%
SHC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SHC Return on Capital Employed

Current Company
8.58%
Current Industry
11.6%
SHC has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SHC vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SHC$1.05B$406.83M$51.38M+7.06%-33.74%
RDNT$1.62B$265.49M$3.04M+10.64%-40.49%
OLK$169.60M-$20.05M-$31.60M+42.02%N/A
NEOG$929.24M$188.76M$1.57M+17.63%-49.27%
GH$563.95M-$433.31M-$479.45M+44.14%N/A
View Top Diagnostic & Research Stocks

SHC earnings dates

Next earnings date
May 2, 2024

Sotera Health Co Earnings & Revenue FAQ

What were SHC's earnings last quarter?

On Invalid Date, Sotera Health Co (NASDAQ: SHC) reported Q4 2023 earnings per share (EPS) of $0.14, up 112.28% year over year. Total Sotera Health Co earnings for the quarter were $38.68 million. In the same quarter last year, Sotera Health Co's earnings per share (EPS) was -$1.14.

If you're new to stock investing, here's how to buy Sotera Health Co stock.

What was SHC's earnings growth in the past year?

As of Q2 2024, Sotera Health Co's earnings has grown year over year. Sotera Health Co's earnings in the past year totalled $51.38 million.

What is SHC's earnings date?

Sotera Health Co's earnings date is Invalid Date. Add SHC to your watchlist to be reminded of SHC's next earnings announcement.

What was SHC's revenue last quarter?

On Invalid Date, Sotera Health Co (NASDAQ: SHC) reported Q4 2023 revenue of $310.24 million up 23.31% year over year. In the same quarter last year, Sotera Health Co's revenue was $251.59 million.

What was SHC's revenue growth in the past year?

As of Q2 2024, Sotera Health Co's revenue has grown 4.54% year over year. This is 4.42 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 0.12%. Sotera Health Co's revenue in the past year totalled $1.05 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.